The report "Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029", is projected to reach USD 2,546.0 billion by 2029 from USD 1,949.4 billion in 2024 at a CAGR of 5.5% during the forecast period.
Browse 907 market data Tables and 63 Figures spread through 718 Pages and in-depth TOC on "Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html
Globally, the growing burden of chronic diseases like diabetes, hypertention, rising aging population globally are anticipated to accelerate the demand for drug delivery, further propelling the adoption of pharmaceutical drug delivery products . Moreover, the growing focus on patient convenience and government initiative to aid affordibility and accessibility are likely to fuel the market growth. Moreover, the increasing investments for new product development and growing adoption of home care settings and self administration owing to its advantages are expecetd to support the pharmaceutical drug delivery market growth during the forecast period.
Risk of needlestick injuries associated with drug delivery products and high cost of development , reducing the affordibiity of drug delivery products amoung patients and healthcare providers are likely to hamper the growth of pharmaceutical drug delivery market
The injectable drug delivery segment, is expected to register the largest market share of the global pharmaceutical drug delivery market in 2023.
The pharmaceutical drug delivery market is segmented based on route of administration. Among route of administration segments, the injectable drug delivery segment held the largest market share and anticipated to grow at a significant pace during forecast period. Owing to increasing prevalence of chronic disease as injectables are used in many therapeutic areas. The injectable route is also a promising alternative for drug delivery over oral route .It also enhances patient compliance and reduce the frequency of dosage administration. Due to growing preference in self-administration and home care, there has been significant development in injectables with a focus to minimize needle complications and pain. These factors are boosting the growth of injectable drug delivery at higher rate.
The hospital segment, is predicted to capture the largest market share of the global pharmaceutical drug delivery market in 2023.
The pharmaceutical drug delivery market is classified into hospitals, ambulatory surgical centers/clinics, diagnostic centers, home care settings, and other settings based on facility of use. The hospital segment is predicted to grow at a significant pace owing to the increasing number of inpatient and outpatient visits in hospitals and the requirement of large volumes of drugs and their respective delivery devices. Additionally, the increase in number of surgeries being performed and rising prevalence of chronic diseases across the globe leads to higher hospital admissions and, in turn, boost the pharmaceutical drug delivery market in this segment.
“The North America market, by region, to register highest growth rate in the forecast period.”
On the basis of region, the pharmaceutical drug delivery market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa. The North America market is likely to witness significant market growth. This is attribute to the rise in geriatric patient population, increasing cases of chronic diseases, moreover improving healthcare infrastructure and the implementation of supportive government initiatives to increase the accessibility drug delivery products. The geographical expanion and presence of key players in the region are likely to support growth of pharmaceutical drug delivery market in North America.
As of 2023, pharmaceutical drug delivery in was dominated by Johnson & Johnson services, inc (US) , Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US) , Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Sanofi (France), Bayer AG (Germany), among others
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]